Summary: The development of technologies to generate MAbs created considerable excitement in oncology because of their potential use in tumor therapy. The use of agonistic monoclonal antibodies against certain targets have emerged as one of the most effective ways to boost immune responses against infectious agents or to fight cancer. Creative Biolabs is specialized in new agonistic antibody discovery. https://www.creative-biolabs.com/Agonistic-Antibody-Discovery-Service.html